^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

OR-S1

i
Other names: OR-S1, OR S1
Associations
Trials
Company:
Daiichi Sankyo, National Cancer Center
Drug class:
EZH2 inhibitor, EZH1 inhibitor
Associations
Trials